Two women smiling at the camera with mountains in the background

Guiding Principles

At its launch event in 2023, the Consortium established four key principles to guide and implement its Action Plan. By continuing to grow the Consortium and adding non-traditional participants, the Consortium aims to extend the reach and momentum to meet cervical cancer elimination goals.

Action Plan

The Consortium’s Action Plan seeks to respond to the needs and challenges that countries and communities face to make cervical cancer history. The action plan will encompass four key areas:

Advocacy and Thought Leadership

  • Unify global stakeholders from the private, public, non-profit and civil society sectors across the three pillars of vaccination, screening, and treatment to accelerate action towards cervical cancer elimination goals.
  • Foster collaboration among partners to enhance synergistic action and impact.
  • Support strategic communications across Consortium-owned and partner
    platforms to galvanize action, foster thought-leadership, and build an
    engaged community.
  • Cultivate an active network of strong champions (cancer survivors, youth
    advocates, women and transgender influencers, and global leaders) to raise
    awareness and win political commitment at the national and local levels.
  • Advocate for integrated and pro-equity approaches to HPV and cervical
    cancer-related policies, funding, and programming by global institutions
    and country governments.
  • Leverage major global health and policy events to amplify advocacy,
    partnerships, and opportunities for the Consortium.

Knowledge Management and Exchange

  • Create a hub that aggregates evidence, data, case studies, and best practices on HPV prevention and cervical cancer elimination.
  • Develop and sustain a ‘learning collective’ among Consortium partners and participants to enable multi-directional dialogue and exchange of ideas, learnings, and opportunities.
  • Share ways to improve integration of primary and secondary prevention services, including holistic policymaking and financing, health systems strengthening, and workforce capacity building.
  • Disseminate best practices for introduction and scale-up across primary and secondary prevention.
  • Harness evidence to advocate for groups at greater risk for HPV and cervical cancer, including women living with HIV, transgender individuals and out-of-school adolescents.
  • Amplify the role and voices of adolescents, youth, and women.
  • Strengthen data collection and analysis on disease burden, mortality, and the coverage of vaccination, screening, and treatment services.
  • Promote access to advancements and innovations across the value chain of prevention, including delivery models, self-sampling, multi-pathogen diagnostics platforms, early treatment options, cold chain innovation, and data management.

Convening of Key Stakeholders

  • Gather global and regional stakeholders to promote cross-country and transdisciplinary exchange and learning for HPV prevention and cervical cancer elimination.
  • Organize country-level meetings at a national and sub-national level to initiate feedback loops and build accountability among stakeholders.
  • Hold customized workshops among government representatives, Consortium partners, and key opinion leaders to disseminate information and facilitate cross-learning.

Country-Based Support

  • Mobilize political will for the prevention and elimination agenda through strategic outreach and engagement with health ministers, First Ladies, multilateral institutions, donors, key influencers, and civil society organizations.
  • Support national and sub-national governments in developing and implementing comprehensive and sustainable policies and plans to prevent HPV and eliminate cervical cancer.
  • Build contextualized investment cases for cervical cancer elimination by collating country-specific evidence, data, and budgeting tools.
  • Support countries in securing sufficient and sustainable financing.
  • Conduct social and behavioral research to understand and lift barriers to
    vaccination, screening, and treatment services.
  • Spur, share, and support locally tailored, community-driven, service delivery models for vaccination, screening, and treatment.